-
Molecular characterization of a renal cell carcinoma PDX cohort
Study
EGAS00001006249
-
Characterization of alternative promoter usage in advanced prostate cancer
Study
EGAS00001006275
-
RNAseq analysis on primary sites Colorectal Cancer xenografts (PRX) samples
Study
EGAS00001007051
-
Integrated genetic analysis of primary CNS lymphoma
Study
EGAS00001007222
-
Hepatoblastoma tumoroid biobank as a key resource for tumour genetics
Study
EGAS00001008251
-
nanostring analysis
Dataset
EGAD00010001535
-
OvCan1
Dataset
EGAD00010000881
-
EGAD00010000622
Dataset
EGAD00010000622
-
Germline and Somatic Genetic Landscape of Pediatric Rhabdomyosarcoma
Study
phs002304
-
Sequencing to Guide Cancer Care (CanSeq)
Study
phs001075
-
MSK SPECTRUM - SPatiotemporal Evolution of Cancer Traced Using Multimodalities
Study
phs002857
-
Genomics to select patients with metastatic breast cancer for targeted therapy (microarray_cytoscan)
Study
EGAS00001005584
-
Genomics to select patients with metastatic breast cancer for targeted therapy (microarray_oncoscan)
Study
EGAS00001005586
-
Genomics to select patients with metastatic breast cancer for targeted therapy (microarray_agilent)
Study
EGAS00001005587
-
Real-time analysis of the cancer genome and fragmentome from plasma and urine short and long cell-free DNA using Nanopore sequencing
Study
EGAS00001006591
-
A Genome-Wide Association Study in Participants Experiencing Breast Cancer Events in High-Risk Postmenopausal Women Receiving Selective Estrogen Receptor Modulators on NSABP Trials P-1 and P-2. A Collaboration Between the NIH Pharmacogenetics Research Network and the RIKEN Yokohama Institute Center for Genomic Medicine
Study
phs000305
-
A Genome-Wide Association Study in Patients Experiencing Breast Events While Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer on NCIC CTG Trial MA.27
Study
phs001043
-
Molecular_characterization_of_invasive_lobular_carcinoma
Study
EGAS00001000292
-
University of Sydney Thyroid Cancer Data Access Committee
Dac
EGAC50000000661
-
Whole-exome sequencing of uterine carcinosarcoma in a young woman with HBOC (tumor-normal pair)
Study
JGAS000883
-
Genetic landscape of pediatric ependymoma
Study
EGAS00001000254
-
WES data from primary CRCs tissues in ctDNA positive patients
Study
EGAS50000000650
-
Whole-genome sequencing study of uveal melanoma
Study
EGAS50000001603
-
Genetic landscape of pediatric Rhabdomyosarcoma
Study
EGAS00001000256
-
Genetic landscape of pediatric Osteosarcoma
Study
EGAS00001000263
-
Dataset of 10 WES from bladders tumors and PBMC of 4 non-muscle invasive bladder cancer patients
Dataset
EGAD50000002008
-
Targeted Sequencing Data for RESOLVE Clinical Trial
Dataset
EGAD50000001711
-
WGS of single CTCs from 4 patients with metastatic cancer
Dataset
EGAD50000001006
-
WES and RNAseq dataset
Dataset
EGAD50000000337
-
The chemotherapeutic CX-5461 is extremely mutagenic and may increase cancer risk
Dataset
EGAD50000000036
-
Exome sequencing data of 15 French Caucasian and 10 African-Caribbean men with prostate Cancer.
Dataset
EGAD00001003306
-
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer - sWGS
Dataset
EGAD00001004379
-
Feasibility of targeted capture sequencing in routinely collected FFPE cancer specimens
Dataset
EGAD00001000354
-
PLCRC study
Dataset
EGAD00001000947
-
Cancer initiation organoids BAM files
Dataset
EGAD00001002719
-
Dataset for white blood cell and cell-free DNA analyses for detection of residual disease in gastric cancew
Dataset
EGAD00001005750
-
Dataset-linking-WGS-samples-in-ega-box-81-via-README-for-study-EGAS00001002923
Dataset
EGAD00001007861
-
February 2021 data update (fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency as part of the International Human Epigenome Consortium.
Dataset
EGAD00001007919
-
Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancer
Dataset
EGAD00001008334
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-4)
Dataset
EGAD00001008625
-
Paired ONT and downsampled Illumina cfDNA dataset
Dataset
EGAD00001009392
-
WXS dataset of Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experience
Dataset
EGAD00001015638
-
CNA differences between RNA-based subtypes of PDAC
Study
EGAS50000001218
-
Dataset for hepatopancreaticobiliary_malignancy-RNA
Dataset
EGAD00001008863
-
Prediction of Resistance and Sensitivity to HER2 Targeted Therapy in the Neoadjuvant Setting
Study
phs003275
-
CUHK Liver Cancer Project DAC
Dac
EGAC00001000214
-
Data Access Committee for German Consortium for Translational Cancer Research (DKTK)
Dac
EGAC00001000217
-
Data Access Committee for COLO829 Somatic reference standard for cancer genome sequencing
Dac
EGAC00001000408
-
Data Access Committee for the Metastatic Breast Cancer Whole-exome sequencing study
Dac
EGAC00001000434
-
Peter Mac Translational Breast Cancer Genomics and Therapeutics Lab Data Access Committee
Dac
EGAC00001000837
-
DAC for Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines
Dac
EGAC00001001101
-
Stanford Data Access Committee for Multi-Region WES of Metastatic Colorectal Cancer
Dac
EGAC00001001164
-
Division of Molecular Oncology, National Cancer Center Research Institute Data Access Committee
Dac
EGAC00001001272
-
Nicola Murray Centre for Ovarian Cancer Research Data Access Committee
Dac
EGAC00001001588
-
Division of Molecular Oncology, National Cancer Center Research Institute Data Access Committee
Dac
EGAC00001002331
-
British Columbia Cancer Agency (BCCA), PHSAs Technology Development Office, Data Access Committee
Dac
EGAC00001002903
-
British Columbia Cancer Agency (BCCA) PHSAs Technology Development Office, Data Access Committee
Dac
EGAC00001002968
-
Division of Molecular Oncology, National Cancer Center Research Institute Data Access Committee
Dac
EGAC00001003030
-
Singapore Gastric Cancer Consortium Data Access Committee
Dac
EGAC00001003138
-
Whole-genome sequenicng of 168 paired Gastric Cancer patients (2nd part) DAC
Dac
EGAC00001002854
-
Whole-genome sequenicng of 168 paired Gastric Cancer patients (3rd part) DAC
Dac
EGAC00001003308
-
EC IO Data Access Committee UMCG
Dac
EGAC50000000334
-
Expression quantitative trait loci influence DNA damage-induced apoptosis in cancer
Dac
EGAC50000000430
-
BC Cancer 5-Aza MDS/AML Data Access Committee
Dac
EGAC50000000536
-
Targetable ERBB2 Mutations in Neurofibroma/Schwannoma Hybrid Nerve Sheath Tumors
Study
EGAS00001003776
-
CML_Discovery_Project
Study
EGAS00001000218
-
Targeted_gene_screen_of_drug_resistant_organoids
Study
EGAS00001001797
-
Quantitative analysis of a novel DNA hypermethylation panel for lung cancer diagnosis
Study
EGAS00001007008
-
Array-based methylation analysis of SDHB-deficient pheochromocytoma and paraganglioma
Study
EGAS00001007844
-
RNAseq analysis on metastatic Colorectal Cancer xenografts samples
Study
EGAS00001006492
-
Evolution_of_the_cancer_epigenome_in_myeloproliferative_neoplasms_TGS
Study
EGAS00001003863
-
Treated and control Patient Derived Xenografts of colorectal cancer (CRC) samples
Study
EGAS00001006973
-
Lobular Carcinomas In Situ Display Intra-Lesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Disease
Study
phs001006
-
Fragmentomics analyses of urinary cell-free DNA permit multi-urologic cancer detection and reduction in tissue biopsies for prostate cancer
Study
EGAS50000001431
-
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Study
EGAS50000000228
-
TRACERx 100: RRBS data from a subset of the first 100 TRACERx tumours
Study
EGAS00001003484
-
VA APOLLO Project - Research for Precision Oncology (RePOP)
Study
phs001374
-
Fred Hutchinson Cancer Research Center - Whole-Exome Sequencing of Hereditary Prostate Cancer Families
Study
phs000350
-
Genomics of Circulating Tumor Cells
Study
phs000717
-
Field_effect_of_healthy_and_diseased_livers_WGS
Study
EGAS00001002413
-
The identification of genetic vulnerabilities in head and neck cancers for the development of novel treatments.
Study
EGAS00001002682
-
Whole exome sequencing of bladder tumors
Study
EGAS50000001248
-
Epigenome wide DNA methylation assay of gingivo-buccal oral squamous cell carcinoma using single base resolution high throughput array
Study
EGAS00001003896
-
Drug development for pediatric cancers: the importance of patient' s genomic data re-use
Blog
drug-development-for-pediatric-cancers
-
Germline elongator mutations in sonic hedgehog medulloblastoma
Study
EGAS00001004126
-
The data access committee for Detecting Liver Cancer Using Cell-Free DNA Fragmentomes
Dac
EGAC00001003279
-
The University of Hong Kong Gastric Cancer Exome Sequencing Project Data Access Committee
Dac
EGAC00001000032
-
Cancer genomics project, the University of Tokyo Data Access Committee
Dac
EGAC00001000087
-
DAC for the study of response to EGFR Blockade in Colorectal Cancer
Dac
EGAC00001000360
-
Data access committee of the Prostate Cancer Research Center, University of Tampere, Finland.
Dac
EGAC00001000423
-
UT MD Anderson Cancer Center Department of Genomic Medicine Lipoasarcoma Data Access Committee
Dac
EGAC00001000821
-
The evolutionary history of human colitis-associated colorectal cancer
Dac
EGAC00001000917
-
DAC for study: Frequent mutation of the FOXA1 untranslated region in prostate cancer
Dac
EGAC00001000962
-
Age-related remodeling of apparently normal esophageal epithelia by common cancer drivers
Dac
EGAC00001001067
-
DAC for study: Evaluation of commercial Guardant360 ctDNA test in metastatic prostate cancer
Dac
EGAC00001001082
-
Immune and Metabolic Features of Brain Metastases Melanoma (Cancer Discovery) Data Access Committee
Dac
EGAC00001001216
-
Mutational Study Committee of a Taiwanese Lung Cancer Cohort (MSCTLCC)
Dac
EGAC00001001614
-
AGECAN - DAC (Interespecies conservation of brain specific DNA methylation in aging and cancer)
Dac
EGAC00001001840
-
Cancer Clinical Research Trust DAC for the 23 WES samples of melanoma subtypes
Dac
EGAC00001002402
-
Genomics characterization of BRAF-V600E colorectal cancer patients treated with anti-BRAF/EGFR
Dac
EGAC00001002669